FindTrial
Sign In

Study on the clinical efficacy and influencing factors of Rebixiao Chinese Formula Granules in the treatment of acute gouty arthritis

Study on the clinical efficacy and influencing factors of Rebixiao Chinese Formula Granules in the treatment of acute gouty arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016593
Enrollment
Unknown
Registered
2018-06-11
Start date
2016-08-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gout

Interventions

Case series:Every patients were given Rebixiao Chinese Formula Granules and the hypurgia in 5 days. Such as be required to drink enough water, 2000-3000ml daily, having low purine diet. They will take

Sponsors

Chongqing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) They are voluntary to enjoy and sign informed consent; (2) The onset of the disease duration of less than 48 hours are eligible to participate.

Exclusion criteria

Exclusion criteria: (1) they are pregnancy or breast-feeding women; (2) they are madman; (3) they have severe infections or hematological diseases; (4) they have active peptic ulcer without recovery this year.

Design outcomes

Primary

MeasureTime frame
The self-made gout disease scale;damp heat syndrome scale;—

Countries

China

Contacts

Public ContactJianping Gan

Chongqing Hospital of Traditional Chinese Medicine

564835676@qq.com+86 18723142536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026